Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetics of Alzheimer’s disease
Theresa König, Elisabeth Stögmann
Wiener Medizinische Wochenschrift (2021) Vol. 171, Iss. 11-12, pp. 249-256
Open Access | Times Cited: 19

Showing 19 citing articles:

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects
Hitesh Chopra, Shabana Bibi, Inderbir Singh, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 27
Molecular functions of MCM8 and MCM9 and their associated pathologies
Noah C. Helderman, Diantha Terlouw, Laia Bonjoch, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106737-106737
Open Access | Times Cited: 12
Deeper insight into ferroptosis: association with Alzheimer’s, Parkinson’s disease, and brain tumors and their possible treatment by nanomaterials induced ferroptosis
Virendra Kumar Yadav, Nisha Choudhary, Amel Gacem, et al.
Redox Report (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 12
Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Cristina Popescu, Constantin Munteanu, Aurelian Anghelescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11272-11272
Open Access | Times Cited: 4
A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
Lanlan Li, Xianfeng Yu, Can Sheng, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Salidroside alleviates Aβ1-42-induced ferroptosis in human neuroblastoma cells by AKT/GSK-3β activation via inhibiting VDAC1
Bensi Zhang, Xiujun Zhang, Waleephan Treebuphachatsakul, et al.
Phytomedicine Plus (2025), pp. 100802-100802
Open Access
The genetic risk factors, molecular pathways, microRNAs, and the gut microbiome in Alzheimer’s disease
N S Aathira, Amanpreet Kaur, Arun Kumar, et al.
Neuroscience (2025)
Closed Access
Metabolic Diffusion in Neuropathologies: The Relevance of Brain-Liver Axis
Sergio Vegas‐Suárez, Jorge Simón, María Luz Martínez‐Chantar, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 15
Role of Artificial Intelligence in Multinomial Decisions and Preventative Nutrition in Alzheimer's Disease
Ariana Soares Dias Portela, Vrinda Saxena, Eric H. Rosenn, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 13
Open Access | Times Cited: 3
Alzheimer’s Disease in Lebanon: Exploring Genetic and Environmental Risk Factors—A Comprehensive Review
Mohamad A. Khaled, Hadi Al-Jamal, Layla Tajer, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 1, pp. 21-40
Closed Access | Times Cited: 3
Epigenetic Biomarkers in Alzheimer's Disease: Diagnostic and Prognostic Relevance
Tapan Behl, Ashishkumar Kyada, R Roopashree, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102556-102556
Closed Access | Times Cited: 3
Immune Response at the Crossroads of Atherosclerosis and Alzheimer's Disease
Natalie Stahr, Elena Galkina
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 13
The Potential of a Stratified Approach to Drug Repurposing in Alzheimer’s Disease
C. H. Anderson, Magda Bucholc, Paula L. McClean, et al.
Biomolecules (2023) Vol. 14, Iss. 1, pp. 11-11
Open Access | Times Cited: 6
Neuronal Transplantation for Alzheimer’s Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation
Phoebe Strell, S. Johnson, Chris Carchi, et al.
Cell Transplantation (2023) Vol. 32, pp. 096368972311647-096368972311647
Open Access | Times Cited: 5
Gender Differences in Demographic and Pharmacological Factors in Patients Diagnosed with Late-Onset of Alzheimer’s Disease
Melissa J. Bailey-Taylor, Nicolas Poupore, Laurie Theriot Roley, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 160-160
Open Access | Times Cited: 8
Rare Pathogenic Variants in Pooled Whole-Exome Sequencing Data Suggest Ciliary Defects and Hyperammoniemia as Possible Causes of Dementia Not Classified as Alzheimer’s Disease or Frontomteporal Dementia
Sena Karachanak-Yankova, Dimitar Serbezov, Mikaela Stancheva, et al.
(2024)
Open Access
Rare Pathogenic Variants in Pooled Whole-Exome Sequencing Data Suggest Hyperammonemia as a Possible Cause of Dementia Not Classified as Alzheimer’s Disease or Frontotemporal Dementia
Sena Karachanak-Yankova, Dimitar Serbezov, G Antov, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 753-753
Open Access
Recent progress in CRISPR-Cas-system for neurological disorders
Sarita Mishra, Shuvomoy Banerjee, Budhi Sagar Tiwari, et al.
Progress in molecular biology and translational science (2024), pp. 231-261
Closed Access
Experimental models and behavioral screening tests in Alzheimer's Drug development: A Review
Bijesh Vatakkeel, R. Mythreyi, Siju EN
Research Journal of Pharmacy and Technology (2024), pp. 6102-6106
Closed Access
A Review of CRISPR Cas9 for Alzheimer’s Disease: Treatment Strategies and Could target APOE e4, APP, and PSEN-1 Gene using CRISPR cas9 Prevent the Patient from Alzheimer’s Disease?
Arga Setyo Adji, Jordan Steven Widjaja, Vira Aulia Kusuma Wardani, et al.
Open Access Macedonian Journal of Medical Sciences (2022) Vol. 10, Iss. F, pp. 745-757
Open Access | Times Cited: 2
Page 1

Scroll to top